BioImpact Capital LLC, 10% Owner at Cullinan Oncology, Inc. (CGEM), sold 6,248 shares at $29.06 ($182K) on 2021-09-16, disclosed to the SEC on 2021-09-20.
Scheduled sale ($182k) by 10% Owner under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $29.06 | 3,124 | $91K | 50.0% |
| 2 | $29.06 | 3,124 | $91K | 50.0% |
| Total | $29.06 avg | 6,248 | $182K | 100% |
| Filing → |
| CGEM | SELL | 2021-09-16 | $602K | — | Filing → |
| CGEM | SELL | 2021-09-13 | $1.4M | — | Filing → |
| ITOS | SELL | 2021-09-13 | $5.5M | — | Filing → |